equine asthma equine asthma Fighting Equine Asthma is a crucial step to improving the well-being of many horses worldwide. The right treatment can make a world of difference.
The little things The little things In 2009 Anna was diagnosed with scleroderma. For her, however, the disease is no reason to give up. On the contrary.
Groundbeaking of vaccine production center in France Groundbeaking of vaccine production center in France Boehringer Ingelheim breaks ground on its strategic vaccine production center for veterinary public health
Boehringer Ingelheim and Fraunhofer partnership Boehringer Ingelheim and Fraunhofer partnership Boehringer Ingelheim and Fraunhofer IME launch collaboration which aims to develop sustainable animal health products
New production center for Veterinary Public Health New production center for Veterinary Public Health Boehringer Ingelheim invests more than €200 million to establish a strategic production center for Veterinary Public Health in Lyon, France.
Official partner to Cat Care for Life Official partner to Cat Care for Life Boehringer Ingelheim announces its new partnership with the CatCareforLife program.
How mobile medical clinics tackle health equity Down Under How mobile medical clinics tackle health equity Down Under We support Heart of Australia to improve health in rural communities
Generalized pustular psoriasis (GPP): a chronic inflammatory disease Generalized pustular psoriasis (GPP): a chronic inflammatory disease Learn more about this chronic inflammatory disease associated with skin and systemic symptoms
Breakthrough Phase 2 survodutide data liver fibrosis MASH Breakthrough Phase 2 survodutide data liver fibrosis MASH Boehringer Ingelheim’s survodutide shows breakthrough improvement in liver fibrosis with no worsening of MASH in 64.5% of patients with F2 and F3 fibrosis
Making-more-health-together-2021 Making-more-health-together-2021 1,200 participants from around the world join virtual convention on November 11-12
Shared science for the best cat diabetes management Shared science for the best cat diabetes management Diabetes mellitus is a common endocrine disease with increasing prevalence in dogs and cats. Learn how science's made management easier.
Striving to revolutionize mental health research Striving to revolutionize mental health research World Mental Health Day: Through a precision psychiatry approach and rich pipeline, we are committed to transforming the mental health landscape.
cat feline diabetes medication treatment eu approval cat feline diabetes medication treatment eu approval Boehringer Ingelheim receives approval for SENVELGO® in Europe: the first oral liquid medication for diabetic cats
Europe needs a vibrant research eco-system Europe needs a vibrant research eco-system At this week's EFPIA Days in Brussels, stakeholders will discuss how to re-establish a research-friendly eco-system in Europe.
2018 Animal Welfare Medals 2018 Animal Welfare Medals 2018 Animal Welfare Medals: Boehringer Ingelheim recognizes outstanding research in cattle, equine, swine, as well as small animals and pet categories
Partnership to further develop pet market in China Partnership to further develop pet market in China Boehringer Ingelheim invests in partnership to further develop the pet market in China, acquires a stake in New Ruipeng Group
New cancer therapeutics collaboration with 3T Bio New cancer therapeutics collaboration with 3T Bio Boehringer Ingelheim and 3T Biosciences collaborate to discover and develop next-generation cancer therapies to address high unmet patient needs
Translating Human Pharma Science into Animal Health Innovation Translating Human Pharma Science into Animal Health Innovation Megan Grether shares her perspectives on the importance of translating human pharma science to accelerate innovation in animal health
NexGard COMBO for cats EMA marketing authorization NexGard COMBO for cats EMA marketing authorization Boehringer Ingelheim received marketing authorization from the EMA (European Medicine Agency) for its NexGard® COMBO topical solution for cats.
cystic fibrosis phase II trial cystic fibrosis phase II trial The first patient has been enrolled in a phase II trial to evaluate an innovative treatment for cystic fibrosis, inhaled via the Respimat® inhaler
CAROLINA-CARMELINA-Asia-analysis CAROLINA-CARMELINA-Asia-analysis CAROLINA® and CARMELINA® outcome trial subgroup analyses demonstrate cardiovascular and renal safety data in Asian adults with type 2 diabetes
Boehringer Ingelheim: Discover the app set to transform animal care in rural India Boehringer Ingelheim: Discover the app set to transform animal care in rural India Learn about the app set to transform animal care in rural India. Women will be empowered and goat welfare will be promoted. From idea to app!
2021 ABCD Young Scientist Award feline health 2021 ABCD Young Scientist Award feline health Young veterinary researchers Julia Klaus and Dr Yasmin Parr receive award for their work into feline SARS-CoV-2 infections and feline leukaemia virus.